DSM Forms 50-50 Joint Venture With Sinochem To Crack Into China's Restricted Anti-Infectives Market
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Netherlands-based Royal DSM announced Dec. 17 that it reached an agreement with Sinochem Group, one of China's biggest central state-owned enterprises, to form a global 50-50 joint venture for anti-infectives. The two companies expect to close the transaction in Q2 2011